After detailed review of clinical trials, the FDA advises that the Pfizer-BioNTech vaccine is safe and effective in preventing serious illness caused by COVID-19, and is fully approved for ages 16 and older.
Emergency use authorization continues for those ages 12 to 15, as well as an additional dose for select immunocompromised individuals.
For more information visit: https://www.fda.gov/news-events/press-announcements/fda-approves-first-covid-19-vaccine